Order Article Reprints

Dermitzakis EV, Vikelis M, Xiromerisiou G, Rallis D, Soldatos P, Litsardopoulos P, Rikos D, Argyriou AA. Nine-Month Continuous Fremanezumab Prophylaxis on the Response to Triptans and Also on the Incidence of Triggers, Hypersensitivity and Prodromal Symptoms of Patients with High-Frequency Episodic Migraine. Journal of Clinical Medicine. 2024; 13(2):386. https://doi.org/10.3390/jcm13020386

Dermitzakis, Emmanouil V., Michail Vikelis, Georgia Xiromerisiou, Dimitrios Rallis, Panagiotis Soldatos, Pantelis Litsardopoulos, Dimitrios Rikos, and Andreas A. Argyriou. 2024. "Nine-Month Continuous Fremanezumab Prophylaxis on the Response to Triptans and Also on the Incidence of Triggers, Hypersensitivity and Prodromal Symptoms of Patients with High-Frequency Episodic Migraine" Journal of Clinical Medicine 13, no. 2: 386. https://doi.org/10.3390/jcm13020386

Dermitzakis, E. V., Vikelis, M., Xiromerisiou, G., Rallis, D., Soldatos, P., Litsardopoulos, P., Rikos, D., & Argyriou, A. A. (2024). Nine-Month Continuous Fremanezumab Prophylaxis on the Response to Triptans and Also on the Incidence of Triggers, Hypersensitivity and Prodromal Symptoms of Patients with High-Frequency Episodic Migraine. Journal of Clinical Medicine, 13(2), 386. https://doi.org/10.3390/jcm13020386